The effect of aspirin on C-reactive protein as a marker of risk in unstable angina

S Kennon1, C P Price, P G Mills

  • 1Department of Cardiology, Bart's and the London NHS Trust, United Kingdom. srok@dircon.co.uk

Insights

Aspirin pretreatment alters the predictive value of C-reactive protein (CRP) for cardiac events in unstable angina. This interaction suggests aspirin modifies inflammatory responses to myocardial injury, impacting event prediction.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Pharmacology

Background:

  • C-reactive protein (CRP) elevation in acute coronary syndromes may indicate myocardial necrosis or inflammation driving atherosclerosis.
  • Aspirin's anti-inflammatory properties or reduction of myocardial necrosis could influence CRP release.
  • The clinical significance of aspirin's effect on CRP in unstable angina requires investigation.

Purpose of the Study:

  • To assess the interaction between aspirin and C-reactive protein (CRP) release in patients with unstable angina.
  • To determine if aspirin pretreatment modifies the prognostic value of CRP for adverse cardiac events.

Main Methods:

  • Prospective cohort study of 304 patients with non-ST-elevation acute coronary syndromes.
  • Serial blood sampling for C-reactive protein (CRP) and troponin I assays.
  • 12-month follow-up for cardiac death and nonfatal myocardial infarction.

Main Results:

  • Patients on aspirin showed lower troponin I concentrations.
  • Maximum CRP concentrations were lower in patients taking aspirin, though not significantly.
  • Significant interaction found: aspirin pretreatment attenuated the predictive value of CRP for 12-month cardiac events.

Conclusions:

  • Prior aspirin therapy significantly influences the association between CRP levels and cardiac events in unstable angina.
  • Aspirin's effect on the acute-phase inflammatory response to myocardial injury is a key mechanism behind this interaction.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...